The Florida Department of Health and the Florida Department of Business and Professional Regulation today announced a second Massachusetts company has issued a voluntary recall of its products.
Ameridose LLC of Westborough, Mass., is recalling all unexpired products in circulation. Its management is associated with the New England Compounding Center, the pharmacy linked to the outbreak of fungal meningitis from contaminated medications.
Food and Drug Administration preliminary findings raised concerns about sterility assurance for products produced at by the Ameridose facility. Health care professionals should stop using any Ameridose products immediately and return them to the company.
Facilities with Ameridose products should call (888) 820-0622 for instructions on how to return the products. A complete list of recalled products is available at www.ameridose.com/news/.
Ameridose does not have any physical locations in Florida. DBPR is working with the Massachusetts Board of Pharmacy to identify facilities in Florida that may have received Ameridose products.
No infections from Ameridose medications have been reported, so the FDA said health care professionals do not need to follow up with patients who have received Ameridose products at this time. However, any patients experiencing adverse effects from the products should contact their health care professionals immediately.
The DOH and DBPR will continue to update department websites at newsroom.doh.state.fl.us/ and www.myfloridalicense.com/dbpr/. DOH also has a toll-free hotline at 1-866-523-7339 for those who may have additional questions.
